Assoz. Prof. Dr. Jens Hartmann
Fachbereichsleiter Medizinische Verfahrenstechnik - Zentrum für Biomedizinische Technologie
- jens.hartmann@donau-uni.ac.at
- +43 2732 893-2623
- Zum Kontaktformular
- Campus Krems, Trakt C, 3. Stock, 3.11
- Universität für Weiterbildung Krems
- Zentrum für Biomedizinische Technologie
- Dr.-Karl-Dorrek-Straße 30
- 3500 Krems
- Österreich
Publikationen (Auszug Forschungsdatenbank)
Cont, D.; Harm, S.; Schildboeck, C.; Kolm, C.; Kirschner, A.K.T.; Farnleitner, A.H.; Pilecky, M.; Zottl, J.; Hartmann, J.; Weber, V. (2024). The neutralizing effect of heparin on blood-derived antimicrobial compounds: impact on antibacterial activity and inflammatory response. Front Immunol, 15: 1373255
Schildböck, C.; Harm, S.; Hartmann, J. (2024). In vitro removal of protein-bound retention solutes by extracorporeal blood purification procedures. Blood Purif, Jan 23: 1-12
Pilecky, M.; Harm, S.; Bauer, C.; Zottl, J.; Emprechtinger, R.; Eichhorn, T.; Schildböck, C.; Ecker, M.; Willheim, M.; Weber, V.; Hartmann, J. (2022). Performance of lateral flow assays for SARS-CoV-2 compared to RT-qPCR. J Infect, Jan 14: S0163-4453(22)00011-1
Harm, S.; Schildböck, C.; Strobl, K.; Hartmann, J. (2021). An in vitro study on factors affecting endotoxin neutralization in human plasma using the Limulus amebocyte lysate test. Sci Rep, 11(1): 4192
Strobl, K.; Harm, S.; Fichtinger, U.; Schildböck, C.; Hartmann, J. (2021). Impact of anion exchange adsorbents on regional citrate anticoagulation. Int J Artif Organs, 44(3): 149-155
Harm, S.; Schildböck, C.; Hartmann, J. (2020). Cytokine removal in extracorporeal blood purification: An in vitro study. Blood Purif, 49(1-2): 33-43
Kielbassa, A.M.; Leimer, M.R.; Hartmann, J.; Harm, S.; Pasztorek, M.; Ulrich, I.B. (2020). Ex vivo investigation on internal tunnel approach/internal resin infiltration and external nanosilver-modified resin infiltration of proximal caries exceeding into dentin. PLoS ONE, 15(1): e0228249
Harm, S.; Lohner, K.; Fichtinger, U.; Schildböck, C.; Zottl, J.; Hartmann, J. (2019). Blood compatibility - an important but often forgotten aspect of the characterization of antimicrobial peptides for clinical application. Int J Mol Sci, 20(21): 5426
Gubensek, J.; Strobl, K.; Harm, S.; Weiss, R.; Eichhorn, T.; Buturovic-Ponikvar, J.; Weber, V.; Hartmann, J. (2018). Influence of citrate concentration on the activation of blood cells in an in vitro dialysis setup. PLoS ONE, 13(6):e0199204: doi: 10.1371/journal.pone.0199204
Harm, S.; Schildböck, C.; Hartmann, J. (2018). Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification. PLoS One, Jan 24;13(1): 10.1371/journal.pone.0191741
Eichhorn, T.; Hartmann, J.; Harm, S.; Linsberger, I.; König, F.; Valicek, G.; Miestinger, G.; Hörmann, C.; Weber, V. (2017). Clearance of selected cytokines with continuous veno-venous hemodialysis using Ultraflux EMiC2 versus Ultraflux AV1000S. Blood Purification, 44(4): 260-266
Hartmann, J.; Harm, S. (2017). Removal of bile acids by extracorporeal therapies: an in vitro study. International Journal of Artificial Organs, doi: 10.5301/ijao.5000643: doi: 10.5301/ijao.5000643
Hartmann, J.; Harm, S. (2017). A new integrated technique for the supportive treatment of sepsis. International Journal of Artificial Organs, 40(1): 4-8
Strobl, K.; Harm, S.; Weber, V.; Hartmann, J. (2017). The role of ionized calcium and magnesium in regional citrate anticoagulation and its impact on inflammatory parameters. International Journal of Artificial Organs, 40(1): 15-21
Harm, S.; Hartmann, J. (2017). Removal of stabilizers from human serum albumin by nanostructured adsorbents. BioNanoMed Congress, March 2017, Krems, Austria
Hartmann, J.; Harm, S. (2017). Cytokine induction in human blood by fractionated bacterial lysates. BioNanoMed Congress, March 2017, Krems, Austria
Harm, S.; Gabor, F.; Hartmann, J. (2016). Low-Dose Polymyxin: an Option for Therapy of Gram-Negative Sepsis. Innate Immunity, 2016: 274-283
Harm, S.; Gruber, A.; Gabor, F.; Hartmann, J. (2016). Adsorption of Selected Antibiotics to Resins in Extracorporeal Blood Purification. Blood Purification, 2016(41): 55-63
Harm, S.; Hartmann, J. (2016). Low-Dose Polymyxin: An Option for Therapy of Gram-Negative Sepsis. Innate Immunity, March 2016. DOI: 10.1177/17534259
Harm, S.; Hartmann, J. (2016). Polymyxin-Coated Nanostructured Materials: An Option for Sepsis Treatment. Journal of Nanomaterials & Molecular Nanotechnology, 10.4172/2324-8777.S4-003
Patente (Auszug Forschungsdatenbank)
Verfahren zum Erfassen der Ionenkonzentration bei citrat-antikoagulierter extrakorporaler Blutreinigung
Method for measuring the ion concentration in citrate-anticoagulated extracorporeal blood purification [Translation]
Zentrum für Biomedizinische Technologie
Patent-Nr: AT505690B1, Status: Lizenz
Dipl.-Ing. Dr. Martin Brandl, Mag. Karin Strobl, MSc, Assoz. Prof. Dr. Jens Hartmann
Dosieranleitung für endotoxinbindende Lipopeptide
Dosing instructions for endotoxin-binding lipopeptides [Translation]
Zentrum für Biomedizinische Technologie
Patent-Nr: WO2014001444A1, Status: Erteilung